By Michele Maatouk
Date: Tuesday 12 Mar 2019
(Sharecast News) - Medical devices maker Smith & Nephew has agreed to buy US biotechnology company Osiris Therapeutics for $19 per share, which is an enterprise value of around $660m.
No recent information was found.
Currency | US Dollars |
Share Price | $ 0.00 |
Closing Price Change | $ 0.00 |
% Change | 0.00 % |
52 Week High | $0.00 |
52 Week Low | $0.00 |
Volume | 0 |
Shares Issued | 34.53m |
You are here: research